PCOS UK Limited 05340952 true 2023-10-01 2024-09-30 2024-09-30 The principal activity of the company is the promotion of education regarding Polycystic Ovarian Syndrome to the professional healthcare industry Digita Accounts Production Advanced 6.30.9574.0 true A J Wilcox R Morman N J Smart 05340952 2023-10-01 2024-09-30 05340952 2024-09-30 05340952 bus:OrdinaryShareClass1 bus:Non-cumulativeNon-redeemableShares 2024-09-30 05340952 core:RetainedEarningsAccumulatedLosses 2024-09-30 05340952 core:ShareCapital 2024-09-30 05340952 core:CurrentFinancialInstruments core:WithinOneYear 2024-09-30 05340952 bus:FRS102 2023-10-01 2024-09-30 05340952 bus:AuditExempt-NoAccountantsReport 2023-10-01 2024-09-30 05340952 bus:FullAccounts 2023-10-01 2024-09-30 05340952 bus:RegisteredOffice 2023-10-01 2024-09-30 05340952 bus:CompanySecretary1 2023-10-01 2024-09-30 05340952 bus:Director3 2023-10-01 2024-09-30 05340952 bus:Director9 2023-10-01 2024-09-30 05340952 bus:OrdinaryShareClass1 bus:Non-cumulativeNon-redeemableShares 2023-10-01 2024-09-30 05340952 bus:EntityNoLongerTradingButTradedInPast 2023-10-01 2024-09-30 05340952 bus:PrivateLimitedCompanyLtd 2023-10-01 2024-09-30 05340952 countries:AllCountries 2023-10-01 2024-09-30 05340952 2023-09-30 05340952 bus:OrdinaryShareClass1 bus:Non-cumulativeNon-redeemableShares 2023-09-30 05340952 core:RetainedEarningsAccumulatedLosses 2023-09-30 05340952 core:ShareCapital 2023-09-30 05340952 core:CurrentFinancialInstruments core:WithinOneYear 2023-09-30 iso4217:GBP xbrli:pure xbrli:shares

Registration number: 05340952

PCOS UK Limited

Annual Report and Unaudited Financial Statements

for the Year Ended 30 September 2024

 

PCOS UK Limited

Contents

Profit and Loss Account

1

Balance Sheet

2

Notes to the Unaudited Financial Statements

3 to 4

 

PCOS UK Limited

Profit and Loss Account for the Year Ended 30 September 2024

The company has not traded during the year. During this year, the company received no income and incurred no expenditure and therefore made neither profit nor loss.

 

PCOS UK Limited

(Registration number: 05340952)
Balance Sheet as at 30 September 2024

Note

2024
£

2023
£

Creditors: Amounts falling due within one year

3

(14,501)

(14,501)

Capital and reserves

 

Called up share capital

4

1

1

Retained earnings

(14,502)

(14,502)

Shareholders' deficit

 

(14,501)

(14,501)

For the financial year ending 30 September 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

For the financial year ending 30 September 2024 the company was entitled to exemption from audit under section 480 of the Companies Act 2006 relating to dormant companies.

Directors' responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and FRS 102 ‘The Financial Reporting Standard Applicable in the UK and Republic of Ireland’.

Approved and authorised by the Board on 25 June 2025 and signed on its behalf by:
 

.........................................
R Morman
Director

 

PCOS UK Limited

Notes to the Unaudited Financial Statements for the Year Ended 30 September 2024

1

General information

The company is a private company limited by share capital, incorporated in England & Wales.

The address of its registered office is:
74A Station Road East
Oxted
Surrey
RH8 0PG
England

These financial statements were authorised for issue by the Board on 25 June 2025.

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.

Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

3

Creditors

Note

2024
£

2023
£

Due within one year

 

Amounts due to related parties

14,501

14,501

 

PCOS UK Limited

Notes to the Unaudited Financial Statements for the Year Ended 30 September 2024

4

Share capital

Allotted, called up and fully paid shares

2024

2023

No.

£

No.

£

Ordinary shares of £1 each

1

1

1

1